Equities Analysts Issue Forecasts for Itron Q2 Earnings

Itron, Inc. (NASDAQ:ITRI - Free Report) - Investment analysts at Roth Capital raised their Q2 2025 earnings estimates for Itron in a research report issued to clients and investors on Friday, May 2nd. Roth Capital analyst C. Moore now expects that the scientific and technical instruments company will earn $1.30 per share for the quarter, up from their prior estimate of $1.18. The consensus estimate for Itron's current full-year earnings is $5.33 per share. Roth Capital also issued estimates for Itron's Q3 2025 earnings at $1.30 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $5.46 EPS and FY2026 earnings at $5.85 EPS.

Several other research firms have also recently commented on ITRI. Oppenheimer raised their target price on Itron from $124.00 to $131.00 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Guggenheim reaffirmed a "buy" rating and issued a $133.00 price objective on shares of Itron in a report on Thursday, April 17th. Canaccord Genuity Group increased their target price on shares of Itron from $130.00 to $132.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. StockNews.com downgraded shares of Itron from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 1st. Finally, Piper Sandler increased their price objective on shares of Itron from $119.00 to $124.00 and gave the company a "neutral" rating in a report on Thursday, February 27th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $127.64.

Itron Trading Up 0.2 %

Itron stock opened at $108.23 on Monday. Itron has a 52-week low of $90.11 and a 52-week high of $124.90. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $4.93 billion, a price-to-earnings ratio of 22.18, a PEG ratio of 0.81 and a beta of 1.31. The firm has a 50-day moving average price of $104.37 and a two-hundred day moving average price of $107.48.

Itron (NASDAQ:ITRI - Get Free Report) last issued its earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 EPS for the quarter, beating analysts' consensus estimates of $1.30 by $0.22. Itron had a return on equity of 19.03% and a net margin of 9.37%. The company had revenue of $607.15 million during the quarter, compared to the consensus estimate of $608.86 million. During the same period in the previous year, the firm posted $1.24 earnings per share. Itron's quarterly revenue was up .6% compared to the same quarter last year.

Institutional Investors Weigh In On Itron

A number of institutional investors have recently bought and sold shares of ITRI. Franklin Resources Inc. increased its holdings in shares of Itron by 611.9% in the 3rd quarter. Franklin Resources Inc. now owns 282,828 shares of the scientific and technical instruments company's stock valued at $31,128,000 after purchasing an additional 243,102 shares during the period. Principal Financial Group Inc. increased its stake in Itron by 4.5% in the 3rd quarter. Principal Financial Group Inc. now owns 248,077 shares of the scientific and technical instruments company's stock valued at $26,497,000 after buying an additional 10,677 shares during the period. GAMMA Investing LLC lifted its position in Itron by 15.6% in the 4th quarter. GAMMA Investing LLC now owns 1,177 shares of the scientific and technical instruments company's stock worth $128,000 after buying an additional 159 shares in the last quarter. Oliver Luxxe Assets LLC boosted its stake in shares of Itron by 4.2% during the 4th quarter. Oliver Luxxe Assets LLC now owns 23,422 shares of the scientific and technical instruments company's stock valued at $2,543,000 after buying an additional 934 shares during the period. Finally, Green Alpha Advisors LLC grew its holdings in shares of Itron by 7.2% during the 4th quarter. Green Alpha Advisors LLC now owns 5,878 shares of the scientific and technical instruments company's stock valued at $638,000 after acquiring an additional 395 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Itron news, Director Mary C. Hemmingsen sold 750 shares of the business's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $107.27, for a total transaction of $80,452.50. Following the sale, the director now directly owns 5,630 shares of the company's stock, valued at $603,930.10. The trade was a 11.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Christopher E. Ware sold 648 shares of the firm's stock in a transaction on Monday, February 24th. The stock was sold at an average price of $92.90, for a total value of $60,199.20. Following the completion of the sale, the senior vice president now directly owns 20,326 shares of the company's stock, valued at approximately $1,888,285.40. This trade represents a 3.09 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,037 shares of company stock worth $385,815 in the last three months. 1.45% of the stock is currently owned by insiders.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.